This review highlights strategies to optimize lipid management, including team-based care, patient adherence interventions, EHR tools, and telehealth, emphasizing multifaceted approaches and long-term implementation research for sustainable cardiovascular risk reduction.

• 125
• 0
• 0
• 0

Post myocardial infarction patients are usually started on high intensity statin Rx. Followup in office will include following lipid panel. Insurance carrier permitting, an injectable lipid lowering medication can be added if LDL is not below 55, but usually insurance only permits addition of injectables if LDL remains above 70 on high intensity...

• 215
• 0
• 0
• 0

Expert consensus highlights LDL-C goal gaps in practice, recommending upfront combination lipid-lowering therapy, including novel agents like bempedoic acid, for high/very high cardiovascular risk and statin-intolerant patients.

• 9
• 0
• 0
• 0

I make sure their lipids are tested and ldl at goal. Many cardiologists expect the pcp to manage ongoing risk factors. Now that psk9 inhibitors are better covered I do add on this therapy to maximum statin and ezetimide if not at goal.

• 0
• 0
• 0
• 0

richard moro many options to get ldl under 55 to prevent recurrence ot intial vascular disease

• 130
• 0
• 0
• 0